Results 201 to 210 of about 716,218 (261)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the perioperative period: withdraw or continue? A multicentre randomised controlled trial. [PDF]

Br J Anaesth
Miggelbrink LA, van Klei WA, Verhaar MC, Asselbergs FW, Spiering W, Buhre WFFA, Hollmann MW, van Lier F, van Dongen EHPA, Schober P, Rettig TCD, Reitsma HJB, van Schaik EPC, Vernooij LM, van Waes JAR.   +14 more
europepmc   +1 more source

Letter to the Editor: "Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes". [PDF]

J Clin Hypertens (Greenwich)
Ayesha S, Ishtiaq S, Ali MI, Huda NU.
europepmc   +1 more source

A Letter to the Editor on "Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Hypertension Combined Prediabetes". [PDF]

J Clin Hypertens (Greenwich)
Khan G.
europepmc   +1 more source

In silico screening and molecular dynamics analysis of natural DHPS enzyme inhibitors targeting Acinetobacter baumannii. [PDF]

Sci Rep
Bhati SK, Anjum F, Shamsi A, Hassan MI, Jain M, Muthukumaran J, Singh RP, Singh AK.   +7 more
europepmc   +1 more source

Withholding vs. continuing angiotensin-converting enzyme inhibitors or angiotensin receptor blockers before surgery: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med
Dou W, Hu JH, Long YQ, Liu H, Ji FH, Sudhan N, Peng K.   +6 more
europepmc   +1 more source

Prognostic impact of angiotensin-converting enzyme inhibitors and dexmedetomidine in acute respiratory distress syndrome: a MIMIC-IV-based retrospective cohort analysis. [PDF]

Front Med (Lausanne)
Hong Q, Yang X, Yang H, Zhou X, Tang J, Wen Z.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pyranoid Spirosugars as Enzyme Inhibitors

Current Organic Synthesis, 2021
Background: Pyranoid spirofused sugar derivatives represent a class of compounds with a significant impact in the literature. From the structural point of view, the rigidity inferred by the spirofused entity has made these compounds object of interest mainly as enzymatic inhibitors, in particular, carbohydrate processing enzymes.
La Ferla, Barbara, D'Orazio, Giuseppe
openaire   +3 more sources

Inhibitors of glyoxalase enzymes

Biochemical and Biophysical Research Communications, 1980
Abstract Both glyoxalase enzymes from various sources are inhibited by nucleotides, nucleosides and a series of structurally related compounds in an apparently cooperative manner. In general, aromatic compounds, which contain heterocyclic nitrogen and/or have amino groups on the aromatic ring, are effective inhibitors of these enzymes.
B, Oray, S J, Norton
openaire   +2 more sources

Enzyme Inhibitors in the Treatment of Hypertension.

Annals of Internal Medicine, 1961
Excerpt The use of enzyme inhibitors in the treatment of hypertension is currently being investigated.
A N, BREST, J H, MOYER
openaire   +2 more sources